FDA product code JCN: Control, Cell Counter, Normal And Abnormal

JCN is the FDA product code for control, cell counter, normal and abnormal. It is a Class II device, regulated under 21 CFR 864.8625 and reviewed by the Hematology panel. FDA has cleared 12 510(k) submissions under JCN, from 7 different applicants. The average 510(k) review took 47 days (median 40). FDA has posted 3 recalls for JCN devices, 3 initiated in the last five years.

Classification

FieldValue
Device nameControl, Cell Counter, Normal And Abnormal
Device classClass II
Regulation21 CFR 864.8625
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every JCN clearance

Top JCN applicants

ApplicantClearancesLatest
Streck Laboratories, Inc.41999-11-30
R&D Systems, Inc.31993-12-06
Bio-Rad11994-06-16
Hematronix, Inc.11990-08-22
Unipath , Ltd.11990-08-22

2 more applicants have JCN clearances. See the full list in Caduvo.

Most recent JCN clearances

510(k)ApplicantDeviceDecision dateReview days
K993825Streck Laboratories, Inc.PARA TECH PLUS RETICS1999-11-3018
K942209Bio-RadLIQUICHEK HEMATOLOGY-16 CONTROL, LOW, NORMAL AND HIGH1994-06-1642
K934497R&D Systems, Inc.CBC-STK(TM) HEMATOLOGY CONTROL/MULTIPLE1993-12-0683
K911582Streck Laboratories, Inc.STAK-CHEX1991-05-2850
K902389Hematronix, Inc.TRI-COUNT 161990-08-2284

Recalls for JCN devices

3 product recalls in 1 recall events; 3 initiated in the last five years and 3 still open. Most recent: 2025-06-04.

YearRecalls
20253

Frequently asked questions

What is FDA product code JCN?

JCN is the FDA product code for control, cell counter, normal and abnormal. It is a Class II device, regulated under 21 CFR 864.8625 and reviewed by the Hematology panel.

What device class is JCN?

Class II, regulation 21 CFR 864.8625. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code JCN?

Across 12 cleared submissions the average was 47 days from receipt to decision (median 40).

Which companies have the most JCN clearances?

Streck Laboratories, Inc. (4); R&D Systems, Inc. (3); Bio-Rad (1); Hematronix, Inc. (1); Unipath , Ltd. (1).

Have JCN devices been recalled?

Yes: 3 product recalls across 1 recall events; the most recent began 2025-06-04.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times